Related Experiment Video
Updated: Dec 2, 2025

05:19
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
2.9K
Development of a depression in Parkinson's disease prediction model using machine learning
1Major in Medical Big Data, College of AI Convergence, Inje University, Gimhae 50834, Gyeonsangnamdo, South Korea. bhwpuma@naver.com.
World Journal of Psychiatry
|November 2, 2020
Summary
Predicting depression in Parkinson's disease (DPD) is crucial for patient well-being. Late motor complications, like levodopa-induced dyskinesia, are key predictors for developing DPD.
Area of Science:
- Neurology
- Geriatrics
- Psychiatry
Background:
- Depression in Parkinson's disease (DPD) significantly impacts patient quality of life.
- Early diagnosis and identification of DPD predictors are essential for effective management.
Purpose of the Study:
- To develop a predictive model for DPD using support vector machines.
- To identify key predictors including sociodemographic factors, health habits, PD symptoms, sleep disorders, and neuropsychiatric indicators.
Main Methods:
- Analysis of 223 patients aged 60+ with Parkinson's disease (PD).
- Depression assessment using the Geriatric Depression Scale (30 items).
- Support vector machine model developed using PD motor signs, REM sleep behavior disorders, and neuropsychological tests.
Main Results:
- Late motor complications, specifically levodopa-induced dyskinesia, emerged as the most significant risk factor for PD motor symptoms.
- Functional weight analysis highlighted the influence of motor symptoms on DPD prediction.
Conclusions:
- Developing customized screening tests for early DPD detection is necessary.
- Continuous monitoring of high-risk groups, identified through the predictive model, is vital for maintaining emotional health in PD patients.
Related Concept Videos
Parkinson's Disease: Treatment
793
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
793
Parkinson's Disease: Overview
1.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.4K

